Intra-Cellular Therapies, Inc.

NASDAQ:ITCI

74.7 (USD) • At close September 18, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q32014 Q22014 Q12013 Q42013 Q32013 Q22013 Q12012 Q4
Revenue 161.388144.866131.506125.81110.12894.73187.43371.8755.07434.75525.51621.60619.00715.57912.4047.3691.8760.8830.06100000000.0050.0310.1150.0950.0980.0040.22800.03100.0570.0030.0660.1240.2190.1680.8280.6680.6430.5980.669
Cost of Revenue 11.3549.910.7029.1297.1636.7516.7885.854.653.1552.5382.0012.041.4551.1410.5560.1290.06919.06621.3423.72824.99133.60635.41932.43930.70326.92918.47212.47921.53921.17923.91825.30123.43422.86528.45817.76318.63211.6414.0462.712.8292,737.0024.1587.7884.9520.517
Gross Profit 150.034134.966120.804116.681102.96587.9880.64566.0250.42431.622.97819.60516.96714.12411.2636.8121.7470.813-19.005-21.34-23.728-24.991-33.606-35.419-32.439-30.703-26.924-18.442-12.364-21.444-21.081-23.914-25.072-23.434-22.835-28.458-17.705-18.629-11.575-3.922-2.49-2.662-2,736.174-3.49-7.145-4.3540.152
Gross Profit Ratio 0.930.9320.9190.9270.9350.9290.9220.9190.9160.9090.9010.9070.8930.9070.9080.9250.9310.921-313.5480000000-5,326.209-599.649-107.755-225.043-215.344-5,482.318-109.7520-744.8010-308.505-5,619.642-175.748-31.523-11.36-15.862-3,306.431-5.225-11.107-7.2780.227
Reseach & Development Expenses 56.18342.83350.77441.5549.79438.02433.86233.27438.53629.04329.45927.03217.29615.05814.29910.27525.20516.00319.06621.3423.72824.99133.60635.41932.43930.70326.92918.47212.47921.53921.17923.91825.30123.43422.86528.45817.76318.63211.6414.0462.712.8296.134.1587.7884.9520.517
General & Administrative Expenses 0012.520008.831000-2.82200040.64839.27437.34632.69622.76415.03615.44311.7059.0177.9726.7296.3815.7845.3186.2556.316.9516.2716.4725.0646.5383.8923.9863.7723.7222.5822.1211.9132.7311.2960.0111.0471.119
Selling & Marketing Expenses 0092.200085.800082.500017.713.24.11.400000000000000000000000000000
SG&A 121.574113.085104.72105.207101.01498.92394.63188.375100.31675.4679.67870.49869.85152.58458.34852.47441.44634.09622.76415.03615.44311.7059.0177.9726.7296.3815.7845.3186.2556.316.9516.2716.4725.0646.5383.8923.9863.7723.7222.5822.1211.9132.7311.2960.0111.0471.119
Other Expenses 001.60200-0.575-0.4360-0.505-0.241-0.155-0.601-1.04-0.299-0.0510-0.031-0.201-0.0610000000-0.246000-0.331000-0.061000-0.0300000000
Operating Expenses 177.757155.918154.901146.394150.144136.372128.057121.649138.347104.262108.98396.92986.10867.34272.59662.74966.6249.89941.82936.37639.17136.69642.62343.39139.16837.08432.71323.7918.73327.84928.13130.18931.77228.49829.40432.34921.74822.40415.3636.6284.8314.7428.865.4530.0111.0471.119
Operating Income -27.723-20.952-34.097-29.713-47.179-48.392-47.412-55.629-87.923-72.662-86.005-77.324-69.141-53.219-61.333-55.936-64.872-49.086-41.769-36.376-39.171-36.696-42.623-43.391-39.168-37.084-32.708-23.759-18.619-27.754-28.033-30.184-31.544-28.498-29.373-32.349-21.691-22.401-15.297-6.504-4.612-4.574-8.033-4.785-0.011-5.401-0.967
Operating Income Ratio -0.172-0.145-0.259-0.236-0.428-0.511-0.542-0.774-1.596-2.091-3.371-3.579-3.638-3.416-4.945-7.591-34.582-55.62-689.1040000000-6,470.478-772.556-162.266-291.269-286.354-6,919.853-138.0810-958.0530-377.957-6,757.388-232.259-52.274-21.035-27.264-9.707-7.164-0.017-9.027-1.445
Total Other Income Expenses Net 11.566.0645.9665.4984.534.3493.3862.1221.320.5480.2710.3930.4210.4840.6440.7531.161.6781.1861.5141.7321.861.8751.8681.7931.6041.4410.8850.8580.8220.7810.7520.710.6560.540.1890.180.1140.10.0880.0780.0310.01-0.126-0-0.238-0.184
Income Before Tax -16.163-14.888-28.131-24.215-42.649-44.043-44.026-53.507-86.603-72.114-85.734-76.931-68.72-52.735-60.689-55.184-63.712-47.407-40.583-34.862-37.44-34.836-40.748-41.523-37.375-35.48-31.267-22.874-17.761-26.932-27.252-29.433-30.834-27.841-28.833-32.16-21.511-22.287-15.198-6.416-4.534-4.543-8.023-4.912-0.011-5.638-1.151
Income Before Tax Ratio -0.1-0.103-0.214-0.192-0.387-0.465-0.504-0.744-1.572-2.075-3.36-3.561-3.616-3.385-4.893-7.489-33.964-53.718-669.540000000-6,185.39-743.787-154.79-282.641-278.38-6,747.526-134.9750-940.4390-374.827-6,723.024-230.748-51.566-20.679-27.078-9.695-7.353-0.017-9.425-1.72
Income Tax Expense 0.0570.3590.4480.0430.1350.01-6.7720.001-2.640.005-0.541-0.0230.0240.0050.01-1.506-2.320.003-1.125-1.5140.002-1.865.266-1.8680.002-1.604-1.058-0.004-0.8580.0020.2330.833-0.71-0.6560.002-0.189-0.18-0.1140.002-0.088-0.078-0.0310.018-0.01-0.005-4.1190.008
Net Income -16.22-15.247-28.579-24.258-42.784-44.053-37.254-53.508-83.963-72.119-85.734-76.908-68.744-52.74-60.699-55.184-63.712-47.411-40.583-34.862-37.441-34.836-40.748-41.523-37.376-35.48-30.209-22.87-17.761-26.934-27.485-30.265-30.834-27.841-28.835-32.16-21.511-22.287-15.199-6.416-4.534-4.543-8.041-4.912-0.011-5.638-1.159
Net Income Ratio -0.101-0.105-0.217-0.193-0.388-0.465-0.426-0.745-1.525-2.075-3.36-3.56-3.617-3.385-4.894-7.489-33.964-53.722-669.540000000-5,976.006-743.657-154.79-282.657-280.76-6,938.406-134.9750-940.4910-374.827-6,723.024-230.772-51.566-20.679-27.078-9.717-7.353-0.017-9.425-1.733
EPS -0.16-0.16-0.3-0.25-0.45-0.46-0.39-0.57-0.89-0.78-1.05-0.95-0.85-0.65-0.76-0.79-0.96-0.73-0.73-0.63-0.68-0.63-0.74-0.76-0.68-0.65-0.56-0.53-0.41-0.62-0.64-0.7-0.71-0.64-0.67-0.91-0.61-0.72-0.52-0.22-0.15-0.17-0.3-0.22-0.001-0.39-0.21
EPS Diluted -0.16-0.16-0.3-0.25-0.45-0.46-0.39-0.57-0.89-0.78-1.05-0.95-0.85-0.65-0.76-0.79-0.96-0.73-0.73-0.63-0.68-0.63-0.74-0.76-0.68-0.65-0.56-0.53-0.41-0.62-0.64-0.7-0.71-0.64-0.67-0.91-0.61-0.72-0.52-0.22-0.15-0.17-0.3-0.22-0.001-0.39-0.21
EBITDA -27.594-20.82-33.961-29.578-47.179-48.392-47.412-55.459-87.923-72.491-86.005-77.19-69.015-53.092-61.333-55.936-64.74-48.937-41.769-36.247-39.066-36.696-42.623-43.296-39.072-37.002-31.267-22.821-18.567-27.704-27.227-29.37-31.495-28.45-29.373-32.115-21.479-22.272-15.198-6.409-4.525-4.532-8.007-4.78-0.011-5.394-0.958
EBITDA Ratio -0.171-0.144-0.258-0.235-0.428-0.511-0.542-0.772-1.596-2.086-3.371-3.573-3.631-3.408-4.945-7.591-34.512-55.451-689.1040000000-6,185.39-742.049-161.818-290.74-278.129-6,733.237-137.8680-958.0530-374.271-6,718.427-230.748-51.514-20.64-27.01-9.676-7.156-0.017-9.017-1.433